Oxford COVID-19 Vaccine: Oxford-AstraZeneca Vaccine ‘Covishield’ Cleared By DCGI

New Delhi: Good news at the start of the new year in the fight against Corona. DCGI gave clearance to Covishield. This has been reported by the news agency. According to the news agency, the British vaccine has been approved by the Drug Controller General of India or DCGI. Approved drug controller for emergency application.

Covid Vaccine

Sources said that when and how the application will be announced next week. After 9 months of fighting with Corona, finally the country is on the way of vaccinated. The Serum Institute partnered with Oxford University and AstraZeneca on the need to bring the Covid-19 vaccine to India immediately.

Meanwhile, on the same day, another good news was received from the Serum Institute of Pune. According to the agency, 4 to 5 crore doses of the vaccine have been prepared. The company, which is one of the largest in the world, has set a target of producing 300 million vaccines this year. Serum claims 92-95 percent success in Covishield vaccine.

The Oxford-AstraZeneca vaccine is being developed by the Pune Serum Institute of India. The name of this Covid-19 vaccine is Covishield. An expert panel from the Central Drugs Standards Control Organization (CDSCO) was reportedly going to recommend approving the vaccine.

A panel of CDSCO experts met today at the Oxford University for the urgent approval of the Covid-19 vaccine. The Director General of Drug Controller General of India (DCGI) has hinted that corona vaccine may be introduced in India in the new year. The dry run of corona vaccine is starting across the country from tomorrow.

Leave a Comment